{
  "id": 20055153,
  "updated": "2019-02-18T19:03:06Z",
  "additionalIndexing": "2841",
  "affairType": {
    "abbreviation": "Qst.",
    "id": 14,
    "name": "Heure des questions. Question"
  },
  "author": {
    "councillor": {
      "code": 2076,
      "gender": "m",
      "id": 326,
      "name": "Günter Paul",
      "officialDenomination": "Günter"
    },
    "faction": {
      "abbreviation": "Groupe S",
      "id": 2,
      "name": "Groupe socialiste"
    },
    "type": "author"
  },
  "deposit": {
    "council": {
      "abbreviation": "CN",
      "id": 1,
      "name": "Conseil national",
      "type": "N"
    },
    "date": "2005-09-26T00:00:00Z",
    "legislativePeriod": 47,
    "session": "4709"
  },
  "descriptors": [
    {
      "key": "L04K01050109",
      "name": "Infektionskrankheit",
      "type": 1
    },
    {
      "key": "L04K01050104",
      "name": "Epidemie",
      "type": 1
    },
    {
      "key": "L05K0105030104",
      "name": "Impfstoff",
      "type": 1
    }
  ],
  "drafts": [
    {
      "consultation": {
        "resolutions": [

        ]
      },
      "federalCouncilProposal": {
      },
      "index": 0,
      "links": [

      ],
      "preConsultations": [

      ],
      "references": [

      ],
      "relatedDepartments": [
        {
          "abbreviation": "DFI",
          "id": 4,
          "name": "Département de l'intérieur",
          "leading": true
        }
      ],
      "states": [
        {
          "date": "/Date(1127685600000+0200)/",
          "id": 27,
          "name": "Liquidé"
        }
      ],
      "texts": [

      ]
    }
  ],
  "handling": {
    "date": "2005-09-26T00:00:00Z",
    "legislativePeriod": 47,
    "session": "4709"
  },
  "language": "fr",
  "relatedAffairs": [

  ],
  "roles": [
    {
      "councillor": {
        "code": 2076,
        "gender": "m",
        "id": 326,
        "name": "Günter Paul",
        "officialDenomination": "Günter"
      },
      "faction": {
        "abbreviation": "Groupe S",
        "id": 2,
        "name": "Groupe socialiste"
      },
      "type": "author"
    }
  ],
  "shortId": "05.5153",
  "state": {
    "id": 27,
    "name": "Liquidé",
    "doneKey": "1",
    "newKey": 0
  },
  "texts": [
    {
      "type": {
        "id": 5,
        "name": "Texte déposé"
      },
      "value": "<p>Le Conseil fédéral est-il conscient de l'importance qu'il y a à disposer d'une entreprise nationale de développement et de production de vaccins, afin d'assurer la sécurité de la Suisse en prévision d'une épidémie?</p><p>Est-il prêt à tout entreprendre, dans les limites des possibilités que lui réserve la loi, pour maintenir en Suisse une entreprise de cette nature?</p>"
    },
    {
      "type": {
        "id": 1,
        "name": "Titre de l'objet"
      },
      "value": "Protection en cas d'épidémie"
    }
  ],
  "title": "Protection en cas d'épidémie"
}